TSE:4928

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Market Cap

JP¥184.8b

Last Updated

2021/06/17 15:46 UTC

Data Sources

Company Financials +

Executive Summary

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. More Details


Snowflake Analysis

Flawless balance sheet average dividend payer.


Similar Companies

Share Price & News

How has Noevir Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4928 is less volatile than 75% of JP stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 4928's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

1.1%

4928

1.3%

JP Personal Products

0.4%

JP Market


1 Year Return

14.7%

4928

2.0%

JP Personal Products

22.6%

JP Market

Return vs Industry: 4928 exceeded the JP Personal Products industry which returned 2.6% over the past year.

Return vs Market: 4928 underperformed the JP Market which returned 23.4% over the past year.


Shareholder returns

4928IndustryMarket
7 Day1.1%1.3%0.4%
30 Day5.9%5.4%3.6%
90 Day0.2%-0.7%-2.3%
1 Year19.3%14.7%3.3%2.0%25.3%22.6%
3 Year-24.2%-31.6%-15.1%-18.2%20.3%12.1%
5 Year112.4%80.0%88.8%76.3%78.4%58.9%

Long-Term Price Volatility Vs. Market

How volatile is Noevir Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Noevir Holdings undervalued compared to its fair value and its price relative to the market?

35.37x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 4928 (¥5410) is trading above our estimate of fair value (¥4119.68)

Significantly Below Fair Value: 4928 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 4928 is good value based on its PE Ratio (35.4x) compared to the JP Personal Products industry average (35.6x).

PE vs Market: 4928 is poor value based on its PE Ratio (35.4x) compared to the JP market (16.4x).


Price to Earnings Growth Ratio

PEG Ratio: 4928 is poor value based on its PEG Ratio (5.4x)


Price to Book Ratio

PB vs Industry: 4928 is overvalued based on its PB Ratio (3.9x) compared to the JP Personal Products industry average (3.1x).


Future Growth

How is Noevir Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

6.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4928's forecast earnings growth (6.6% per year) is above the savings rate (0%).

Earnings vs Market: 4928's earnings (6.6% per year) are forecast to grow slower than the JP market (13% per year).

High Growth Earnings: 4928's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4928's revenue (3% per year) is forecast to grow slower than the JP market (5.2% per year).

High Growth Revenue: 4928's revenue (3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4928's Return on Equity is forecast to be low in 3 years time (14%).


Past Performance

How has Noevir Holdings performed over the past 5 years?

3.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4928 has high quality earnings.

Growing Profit Margin: 4928's current net profit margins (10.5%) are lower than last year (11.8%).


Past Earnings Growth Analysis

Earnings Trend: 4928's earnings have grown by 3% per year over the past 5 years.

Accelerating Growth: 4928's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4928 had negative earnings growth (-23.2%) over the past year, making it difficult to compare to the Personal Products industry average (-17.7%).


Return on Equity

High ROE: 4928's Return on Equity (11.1%) is considered low.


Financial Health

How is Noevir Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 4928's short term assets (¥47.1B) exceed its short term liabilities (¥9.2B).

Long Term Liabilities: 4928's short term assets (¥47.1B) exceed its long term liabilities (¥20.0B).


Debt to Equity History and Analysis

Debt Level: 4928 is debt free.

Reducing Debt: 4928 has not had any debt for past 5 years.

Debt Coverage: 4928 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 4928 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Noevir Holdings's current dividend yield, its reliability and sustainability?

3.79%

Current Dividend Yield


Upcoming Dividend Payment

TodayJun 18 2021Ex Dividend DateSep 29 2021Dividend Pay DateDec 07 202169 days from Ex DividendBuy in the next 103 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 4928's dividend (3.79%) is higher than the bottom 25% of dividend payers in the JP market (1.31%).

High Dividend: 4928's dividend (3.79%) is in the top 25% of dividend payers in the JP market (2.98%)


Stability and Growth of Payments

Stable Dividend: 4928's dividends per share have been stable in the past 10 years.

Growing Dividend: 4928's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its high payout ratio (134%), 4928's dividend payments are not well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

10.3yrs

Average board tenure


CEO

Takashi Okura

3.42yrs

Tenure

Mr. Takashi Okura serves as its President at Noevir Holdings Co., Ltd. Mr. Okura has been a Director and Chief Executive Officer at Noevir Holdings Co. since 2018. Mr. Okura had been the Representative Dir...


Board Members

Experienced Board: 4928's board of directors are seasoned and experienced ( 10.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Noevir Holdings Co., Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Noevir Holdings Co., Ltd.
  • Ticker: 4928
  • Exchange: TSE
  • Founded: 1964
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: JP¥184.787b
  • Shares outstanding: 34.16m
  • Website: https://www.noevirholdings.co.jp

Number of Employees


Location

  • Noevir Holdings Co., Ltd.
  • 7-6-15 Ginza
  • Chuo-ku
  • Tokyo
  • 104-8208
  • Japan

Listings


Biography

Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada,...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/06/17 15:46
End of Day Share Price2021/06/17 00:00
Earnings2021/03/31
Annual Earnings2020/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.